AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 121 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $162,192 | +24.6% | 142,274 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $130,181 | +162626.2% | 142,274 | 0.0% | 0.00% | +100.0% |
Q1 2023 | $80 | -2.4% | 142,274 | 0.0% | 0.00% | -50.0% |
Q4 2022 | $82 | -99.8% | 142,274 | -3.0% | 0.00% | +100.0% |
Q3 2022 | $46,000 | -11.5% | 146,708 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $52,000 | -50.9% | 146,708 | -0.3% | 0.00% | -50.0% |
Q1 2022 | $106,000 | +278.6% | 147,199 | +1070.4% | 0.00% | – |
Q4 2021 | $28,000 | -85.5% | 12,577 | -75.4% | 0.00% | -100.0% |
Q2 2021 | $193,000 | -68.1% | 51,044 | -71.5% | 0.00% | -66.7% |
Q1 2021 | $605,000 | +23.0% | 178,870 | +1.8% | 0.01% | -14.3% |
Q4 2020 | $492,000 | +144.8% | 175,779 | +732.9% | 0.01% | +100.0% |
Q1 2018 | $201,000 | +14.9% | 21,105 | +73.6% | 0.01% | +40.0% |
Q2 2017 | $175,000 | +6.7% | 12,155 | -31.6% | 0.01% | 0.0% |
Q1 2017 | $164,000 | -20.0% | 17,777 | -9.9% | 0.01% | 0.0% |
Q4 2016 | $205,000 | +22.8% | 19,728 | +7.2% | 0.01% | +25.0% |
Q3 2016 | $167,000 | +18.4% | 18,410 | -2.1% | 0.00% | +33.3% |
Q2 2016 | $141,000 | -15.6% | 18,798 | +1.6% | 0.00% | -25.0% |
Q1 2016 | $167,000 | – | 18,498 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alerce Investment Management, L.P. | 4,652,561 | $10,515,000 | 10.70% |
Orchard Capital Management, LLC | 1,593,531 | $3,601,000 | 1.06% |
Nantahala Capital Management | 4,918,565 | $11,116,000 | 0.39% |
Ardent Capital Management, Inc. | 168,811 | $382,000 | 0.25% |
Birchview Capital, LP | 100,000 | $226,000 | 0.15% |
Nantahala Capital Management | 1,000,000 | $2,260,000 | 0.08% |
PDT Partners, LLC | 433,400 | $979,000 | 0.08% |
Woodline Partners LP | 2,231,966 | $5,044,000 | 0.07% |
Virtus ETF Advisers LLC | 69,015 | $156,000 | 0.06% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 2,737,900 | $6,188,000 | 0.04% |